Literature DB >> 23844334

Immunity and inflammation in neurodegenerative diseases.

Giuseppe Cappellano1, Miryam Carecchio, Thomas Fleetwood, Luca Magistrelli, Roberto Cantello, Umberto Dianzani, Cristoforo Comi.   

Abstract

Immune reactions inside the central nervous system are finely regulated, thanks to the presence of several checkpoints that have the fundamental purpose to preserve this fragile tissue form harmful events. The current knowledge on the role of neuroinflammation and neuro-immune interactions in the fields of multiple sclerosis, Alzheimer's disease and Parkinson's disease is reviewed. Moreover, a focus on the potential role of both active and passive immunotherapy is provided. Finally, we propose a common perspective, which implies that, under pathological conditions, inflammation may exert both detrimental and protective functions, depending on local factors and the timing of immune activation and shutting-off systems.

Entities:  

Keywords:  Alzheimer’s disease; Multiple sclerosis; Parkinsons disease; neuro-immnue interactions; neuroinflammation

Year:  2013        PMID: 23844334      PMCID: PMC3703122     

Source DB:  PubMed          Journal:  Am J Neurodegener Dis        ISSN: 2165-591X


  180 in total

1.  Anti-cytokine autoantibodies in autoimmune diseases.

Authors:  Giuseppe Cappellano; Elisabetta Orilieri; Abiy D Woldetsadik; Elena Boggio; Maria F Soluri; Cristoforo Comi; Daniele Sblattero; Annalisa Chiocchetti; Umberto Dianzani
Journal:  Am J Clin Exp Immunol       Date:  2012-11-15

2.  Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease.

Authors:  R E Mrak; J G Sheng; W S Griffin
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

3.  T cell vaccination in secondary progressive multiple sclerosis.

Authors:  J Correale; B Lund; M McMillan; D Y Ko; K McCarthy; L P Weiner
Journal:  J Neuroimmunol       Date:  2000-07-24       Impact factor: 3.478

4.  Inflammasome-derived IL-1β regulates the production of GM-CSF by CD4(+) T cells and γδ T cells.

Authors:  John R Lukens; Maggie J Barr; David D Chaplin; Hongbo Chi; Thirumala-Devi Kanneganti
Journal:  J Immunol       Date:  2012-02-17       Impact factor: 5.422

5.  Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease.

Authors:  Eliezer Masliah; Edward Rockenstein; Anthony Adame; Michael Alford; Leslie Crews; Makoto Hashimoto; Peter Seubert; Michael Lee; Jason Goldstein; Tamie Chilcote; Dora Games; Dale Schenk
Journal:  Neuron       Date:  2005-06-16       Impact factor: 17.173

6.  Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity.

Authors:  Tetsuya Mizuno; Yukiko Doi; Hiroyuki Mizoguchi; Shijie Jin; Mariko Noda; Yoshifumi Sonobe; Hideyuki Takeuchi; Akio Suzumura
Journal:  Am J Pathol       Date:  2011-08-26       Impact factor: 4.307

7.  Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline.

Authors:  Cristoforo Comi; Miryam Carecchio; Annalisa Chiocchetti; Stefania Nicola; Daniela Galimberti; Chiara Fenoglio; Giuseppe Cappellano; Francesco Monaco; Elio Scarpini; Umberto Dianzani
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

8.  The changing phenotype of microglia from homeostasis to disease.

Authors:  Xiao-Guang Luo; Sheng-Di Chen
Journal:  Transl Neurodegener       Date:  2012-04-24       Impact factor: 8.014

9.  Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation.

Authors:  Mark R Kotter; Wen-Wu Li; Chao Zhao; Robin J M Franklin
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

10.  HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis.

Authors:  Boel Brynedal; Kristina Duvefelt; Gudrun Jonasdottir; Izaura M Roos; Eva Akesson; Juni Palmgren; Jan Hillert
Journal:  PLoS One       Date:  2007-07-25       Impact factor: 3.240

View more
  56 in total

Review 1.  The Central Nervous System and the Gut Microbiome.

Authors:  Gil Sharon; Timothy R Sampson; Daniel H Geschwind; Sarkis K Mazmanian
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

Review 2.  Models and mechanisms of repeat expansion disorders: a worm's eye view.

Authors:  Paige Rudich; Todd Lamitina
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

3.  Naringenin Decreases α-Synuclein Expression and Neuroinflammation in MPTP-Induced Parkinson's Disease Model in Mice.

Authors:  Sugumar Mani; Sathiya Sekar; Rajamani Barathidasan; Thamilarasan Manivasagam; Arokiasamy Justin Thenmozhi; Murugan Sevanan; Saravana Babu Chidambaram; Musthafa Mohamed Essa; Gilles J Guillemin; Meena Kishore Sakharkar
Journal:  Neurotox Res       Date:  2018-02-09       Impact factor: 3.911

Review 4.  Neuroinflammation, Gut Microbiome, and Alzheimer's Disease.

Authors:  Li Lin; Li Juan Zheng; Long Jiang Zhang
Journal:  Mol Neurobiol       Date:  2018-03-09       Impact factor: 5.590

5.  Vinpocetine regulates levels of circulating TLRs in Parkinson's disease patients.

Authors:  Zhang Ping; Wu Xiaomu; Xie Xufang; Shao Liang
Journal:  Neurol Sci       Date:  2018-10-12       Impact factor: 3.307

6.  Yorkie Regulates Neurodegeneration Through Canonical Pathway and Innate Immune Response.

Authors:  Sandeep Kumar Dubey; Madhu G Tapadia
Journal:  Mol Neurobiol       Date:  2017-01-19       Impact factor: 5.590

7.  Plasma signature of neurological disease in the monogenetic disorder Niemann-Pick Type C.

Authors:  Md Suhail Alam; Michelle Getz; Sue Yi; Jeffrey Kurkewich; Innocent Safeukui; Kasturi Haldar
Journal:  J Biol Chem       Date:  2014-01-31       Impact factor: 5.157

Review 8.  Beta2-Adrenoceptor Agonists in Parkinson's Disease and Other Synucleinopathies.

Authors:  Luca Magistrelli; Cristoforo Comi
Journal:  J Neuroimmune Pharmacol       Date:  2019-01-07       Impact factor: 4.147

9.  Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  S Buttini; G Cappellano; P Ripellino; C Briani; D Cocito; M Osio; R Cantello; U Dianzani; C Comi
Journal:  Genes Immun       Date:  2014-10-30       Impact factor: 2.676

Review 10.  The Mechanobiology of Aging.

Authors:  Jude M Phillip; Ivie Aifuwa; Jeremy Walston; Denis Wirtz
Journal:  Annu Rev Biomed Eng       Date:  2015       Impact factor: 9.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.